Miragen Therapeutics Stock Price - MGEN

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Miragen Therapeutics Inc MGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.03853 -4.45% 0.827469 0.8574 0.785 0.85 0.866 20:00:00
Bid Price Ask Price Spread Spread % News
0.79 1.10 0.31 28.18% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
188 53,158 $ 0.8176543 $ 43,465 192,289 0.6501 - 6.5999
Last Trade Time Type Quantity Stock Price Currency
16:00:00 5 $ 0.82 USD

Miragen Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 25.69M 31.05M $ -32.70M -1.09 - 29.83M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 7.00 3.90%

more financials information »

Miragen Therapeutics News

Date Time Source News Article
10/16/201908:30Edgar (US Regulatory)Current Report Filing (8-k)
8/23/201918:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/15/201908:00GlobeNewswire Inc.miRagen Therapeutics to Present a Corporate Overview at the..
8/12/201908:00GlobeNewswire Inc.miRagen Therapeutics to Present a Corporate Overview at the..
8/08/201906:04Edgar (US Regulatory)Quarterly Report (10-q)
8/07/201916:01Edgar (US Regulatory)Current Report Filing (8-k)
7/24/201908:00GlobeNewswire Inc.Miragen Therapeutics to Report Second Quarter 2019 Financial..

Latest MGEN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.991.390.7850.9430138435,891-0.16253-16.42%
1 Month0.85151.390.65010.8542267183,008-0.02403-2.82%
3 Months2.032.140.65011.13259,284-1.20-59.24%
6 Months2.733.650.65011.65194,972-1.90-69.69%
1 Year4.546.59990.65012.40202,523-3.71-81.77%
3 Years11.1118.000.65015.21161,630-10.28-92.55%
5 Years11.1118.000.65015.21161,630-10.28-92.55%

Miragen Therapeutics Description

Miragen Therapeutics Inc is a US-based clinical-stage biopharmaceutical company discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics. The company's main product candidates, MRG-106, MRG-201, MRG-107, and MRG-110. MRG-106 and MRG-201 are currently in Phase 1 clinical trials. The company mainly focuses on developing such therapeutics which will target blood cancers, pathological fibrosis, and revascularization.
Your Recent History
Miragen Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191024 04:09:18